Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edus H Warren

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Blood|May 28, 2009
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHDAfonso C Vigorito, Paulo V Campregher, Barry E Storer, et al.
Blood|January 5, 2006
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLLAnthony G Brickner, Anne M Evans, Jeffrey K Mito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionJeffrey S Miller, Edus H Warren, Marcel R M van den Brink, et al.
Blood Advances|June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.
Haematologica|January 28, 2017
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamideChristopher G Kanakry, Giorgos Bakoyannis, Susan M Perkins, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Blood Advances|January 4, 2018
High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesisKatharine A Lombardo, David G Coffey, Alicia J Morales, et al.
Blood|June 18, 2016
Genetic risk factors for sclerotic graft-versus-host diseaseYoshihiro Inamoto, Paul J Martin, Mary E D Flowers, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2019
Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution ExperienceJason P Cooper, Sirin Khajaviyan, Stephen D Smith, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Blood|May 28, 2009
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHDAfonso C Vigorito, Paulo V Campregher, Barry E Storer, et al.
Blood|January 5, 2006
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLLAnthony G Brickner, Anne M Evans, Jeffrey K Mito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionJeffrey S Miller, Edus H Warren, Marcel R M van den Brink, et al.
Blood Advances|June 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.
Haematologica|January 28, 2017
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamideChristopher G Kanakry, Giorgos Bakoyannis, Susan M Perkins, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Blood Advances|January 4, 2018
High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesisKatharine A Lombardo, David G Coffey, Alicia J Morales, et al.
Blood|June 18, 2016
Genetic risk factors for sclerotic graft-versus-host diseaseYoshihiro Inamoto, Paul J Martin, Mary E D Flowers, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2019
Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution ExperienceJason P Cooper, Sirin Khajaviyan, Stephen D Smith, et al.
Pageof 9